04:38 PM EST, 11/17/2025 (MT Newswires) -- LifeMD ( LFMD ) reported a Q3 net loss late Monday of $0.10 per diluted share, narrowing from the loss of $0.13 a year earlier.

Two analysts polled by FactSet expected a loss of $0.02.

Revenue in the three months ended Sept. 30 rose to $60.2 million from $53.3 million a year earlier.

Three analysts surveyed by FactSet expected $62.1 million.

Following the WorkSimpli divestiture, the company expects Q4 revenue of $45 million to $46 million and full-year revenue of $192 million to $193 million.

Three analysts project $62.5 million in Q4 and $252.6 million in the full year.

LifeMD ( LFMD ) shares fell 14% in after-hours trading.